SCHEMBL31346130

SCHEMBL31346130

Oc1cc(Cl)c(OC(F)(F)F)cc1I

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGK1 P00558 1/20 0.39
▸ HPGD P15428 2/20 0.34
▸ NR1I2 O75469 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TTR P02766 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HSPA5 P11021 1/20 0.34
▸ CBR1 P16152 1/20 0.34
▸ TBXA2R P21731 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ AGTR1 P30556 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ KMO O15229 2/20 0.34
▸ NOTUM Q6P988 2/20 0.34
▸ SLC1A5 Q15758 2/20 0.33
▸ APP P05067 1/20 0.33
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26607321 1.00 PGK1 (0.39) PGK1HPGDNR1I2LMNATTR
SCHEMBL17959939 0.79 EPHX2 (0.40) APP
SCHEMBL19914321 0.78 HPGD (0.39) PGK1HPGDNR1I2LMNATTR
SCHEMBL26607116 0.78 PGK1 (0.42) PGK1HPGDNR1I2LMNATTR
SCHEMBL17744226 0.78 PGK1 (0.39) PGK1KMONOTUMSLC1A5APP
SCHEMBL3137556 0.76 TSHR (0.42) PGK1HPGDNR1I2LMNATTR
SCHEMBL19914318 0.74 ALDH1A1 (0.40) PGK1HPGDKMONOTUMSLC1A5
SCHEMBL19899524 0.71 ALDH1A1 (0.41) PGK1HPGDLMNATTRAPP
SCHEMBL31379539 0.71 TMPRSS4 (0.38) HPGDHSP90AA1NOTUMTSHRHSD17B10
SCHEMBL17959909 0.71 TMPRSS4 (0.38) HPGDHSP90AA1NOTUMTSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712967-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST Enveda Therapeutics, Inc. (US) 2026-03-25 — — EP disclosed
WO-2024239000-A2 G-PROTEIN COUPLED RECEPTOR ANTAGONIST ENVEDA THERAPEUTICS, INC. (US) 2024-11-21 — — WO disclosed
Send feedback